Measurement of bradykinin and kallidin peptides provides insights into the tissue and plasma kallikrein-kinin systems in physiological and pathological states such as heart failure.
No takes yet. Share an insight, caveat, or question.
Informs kinin assessment in heart failure and ACE inhibitor effects; leaves open therapeutic implications pending prospective validation.
Duncan J. Campbell (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: